2025年神经毒素全球市场报告

预计未来几年神经毒素市场规模将快速成长，到2029年将达到122.5亿美元，复合年增长率为11.2%。预测期内的增长可归因于神经病学应用的不断扩展、对美容手术的持续需求、配方创新、消费者意识的提升以及美容旅游业的蓬勃发展。预测期内的主要趋势包括药物传递技术的进步、神经毒素开发与研究的合作、市场对神经毒素行业监管变化的反应、神经毒素与多模态治疗方案的整合、对持久疗效的关注以及患者满意度。

未来五年的预测成长率为11.2%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能会影响美国的美容和神经科医疗实践，因为爱尔兰和瑞典生产的肉毒桿菌毒素产品价格上涨，从而提高治疗和美容用途的成本。由于互惠关税以及贸易紧张局势和限制升级对全球经济和贸易的负面影响，其影响可能会更加广泛。

神经毒素市场的预期成长预计将受到旨在改善外观的整容手术激增的推动。整容手术涵盖各种医疗介入措施，其主要目的是增强或改变个人的外观。这一趋势受到社会、技术和文化因素的影响，以及人们对整容手术益处日益增长的认识。神经毒素透过放鬆某些肌肉，在减少皱纹和细纹的出现方面发挥关键作用。例如，美国整形外科医师协会于2022年8月进行的一项关于整容手术的调查显示，整容手术的需求显着增加，美国四分之三的整形外科医生指出需求有所增加，30% 的外科医生报告其整容手术业务翻了一番。旨在改善外观的整容手术激增是推动神经毒素市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球神经毒素：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球神经毒素市场：成长率分析
• 全球神经毒素市场表现：规模与成长，2019-2024
• 全球神经毒素市场预测：2024-2029年及2034年规模与成长
• 全球神经毒素：总目标市场（TAM）

第六章 市场细分

• 全球神经毒素市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 肉毒桿菌
• Dysport
• Xeomin
• 其他产品
• 全球神经毒素市场：按应用、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 治疗
• 美学的
• 全球神经毒素市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 专科诊所
• 皮肤科诊所
• 其他最终用户
• 全球神经毒素市场：按肉毒桿菌、类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 化妆品用途
• 治疗用途
• 全球神经毒素市场：Dysport细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 化妆品应用
• 医学指征
• 全球神经毒素市场： Xeomin细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 美容护理
• 治疗应用
• 全球神经毒素市场：依产品类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 杰沃
• 新型神经毒素

第七章 区域和国家分析

• 全球神经毒素市场：区域表现与预测，2019-2024 年、2024-2029 年、2034 年
• 全球神经毒素市场：国家、表现与预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 神经毒素市场：竞争格局
• 神经毒素市场：公司简介
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
  • Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Supernus Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Merz Pharma GmbH & Co KGaA
• Hugel Inc.
• Evolus Inc.
• Medytox Inc.
• Croma-Pharma GmbH
• Revance Therapeutics Inc.
• US WorldMeds
• Gufic Biosciences Ltd.
• Hironic Co. Ltd.
• Allergan
• List Biological Laboratories
• Lanzhou Institute of Biological Products Co. Ltd.
• Sinclair Pharma
• Vida Aesthetics
• Aquavit Holdings LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年神经毒素市场：提供新机会的国家
• 2029年神经毒素市场：细分市场带来新机会
• 2029年神经毒素市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

A neurotoxin is a substance that is specifically harmful to nerve cells (neurons) or the nervous system. These toxins function by inhibiting cellular processes within neurons. Neurotoxins are used to temporarily diminish wrinkles by paralyzing certain muscles and to treat conditions such as muscle spasticity, migraines, and excessive sweating. Additionally, they are utilized in research to explore nerve function and the mechanisms of neuronal signaling, contributing to the understanding of neurological disorders.

The primary products classified as neurotoxins include well-known brands such as Botox, Dysport, Xeomin, and others. Botox, derived from the bacteria Clostridium botulinum, is a notable neurotoxin used for both cosmetic and medical purposes. It is employed to temporarily reduce the appearance of wrinkles and to treat certain muscular conditions. These neurotoxin products find applications in therapeutic and aesthetic contexts, with end-users ranging from hospitals and specialty clinics to dermatology clinics and other relevant healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown strongly in recent years. It will grow from $7.35 billion in 2024 to $8.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to a rise in aesthetic procedures, therapeutic applications, advancements in the cosmetic industry, a growing aging population, and increasing acceptance of non-surgical procedures

The neurotoxin market size is expected to see rapid growth in the next few years. It will grow to $12.25 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expanding applications in neurology, continued demand for aesthetic procedures, innovation in formulations, rising consumer awareness, and expansion of cosmetic tourism. Major trends in the forecast period include advancements in drug delivery techniques, collaborations for neurotoxin development and research, market response to regulatory changes in the neurotoxin industry, integration of neurotoxins in multimodal treatment plans, focus on long-lasting effects, and patient satisfaction.

The forecast of 11.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions may impact U.S. cosmetic and neurology practices by inflating prices of botulinum toxin products manufactured in Ireland and Sweden, resulting in higher costs for both therapeutic and aesthetic applications. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the neurotoxin market is expected to be propelled by the surge in cosmetic procedures aimed at improving appearance. Cosmetic procedures encompass a diverse range of medical interventions undertaken with the primary objective of enhancing or altering an individual's physical appearance. This trend is influenced by societal, technological, and cultural factors, coupled with increased awareness of the benefits associated with cosmetic procedures. Neurotoxins play a crucial role in these procedures by relaxing specific muscles, thereby reducing the appearance of wrinkles and fine lines. For instance, a cosmetic surgery survey by the American Society of Plastic Surgeons in August 2022 revealed a significant increase in demand for cosmetic procedures, with 3 out of 4 plastic surgeons in the USA noting a rise in demand, and 30% reporting a doubling of their cosmetic procedure businesses. This surge in cosmetic procedures to enhance appearance is a key driver fueling the growth of the neurotoxin market.

The increasing aging population is anticipated to drive the growth of the neurotoxin market in the future. The term aging population refers to a demographic trend marked by a rising proportion of elderly individuals within a society or population. This aging demographic often seeks neurotoxin-based treatments, such as Botox, to address age-related cosmetic concerns like wrinkles and facial lines, favoring non-invasive solutions that enhance their appearance and promote a more youthful, rejuvenated look. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, projected that the population of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. During the same period, this age group's share of the overall population is expected to grow from 17% to 23%. Therefore, the growing aging population is driving the expansion of the neurotoxin market.

The innovation of facial aesthetic products is a notable trend gaining popularity in the neurotoxins market, with companies actively engaged in developing and introducing novel products to sustain their positions. One example is Evolus Inc., a US-based medical aesthetics company, which received approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxinA). Nuceiva is a neurotoxin specifically designed for aesthetic purposes, aiming to temporarily enhance the appearance of moderate glabellar lines in adult patients. By blocking nerve impulses to facial muscles, the product induces muscle relaxation, smoothing wrinkles resulting from facial expressions, squinting, and frowning.

Major companies operating in the neurotoxins market are emphasizing innovative products, including facial gel serums, with the goal of enhancing patient satisfaction. An example is the ready-to-use BoNT-A neuromodulator, a pre-formulated and prepared Botulinum Toxin Type A (BoNT-A) product. This product offers a convenient and standardized solution for healthcare practitioners in cosmetic or therapeutic applications. In September 2022, Entod Pharmaceuticals, an Indian-based pharmaceutical company, launched Vasuki, a facial gel serum based on synthetic tripeptide snake venom neurotoxin. The serum is formulated to gently relax muscle contractions under the skin, potentially reducing the appearance of wrinkles and fine lines.

In July 2023, Priveterra Acquisition Corp., a US-based special purpose acquisition company, acquired AEON Biopharma, Inc. for an undisclosed amount. This acquisition aims to create a publicly traded entity focused on advancing AEON's proprietary neurotoxin, ABP-450, which is designed to treat severe conditions such as chronic migraines. The deal intends to utilize up to $125 million in secured funding to support AEON's clinical development and commercialization efforts, thereby strengthening its position in the biopharmaceutical industry and driving growth in the neurosciences market. AEON Biopharma, Inc. is a US-based biopharmaceutical company that produces neurotoxins.

Major companies operating in the neurotoxin market include AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals, Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., US WorldMeds, Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, List Biological Laboratories, Lanzhou Institute of Biological Products Co. Ltd., Sinclair Pharma, Vida Aesthetics, Aquavit Holdings LLC, PharmaResearch Products Co.Ltd, Entod Pharmaceuticals, Object Pharma Inc.

North America was the largest region in the neurotoxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Botox; Dysport; Xeomin; Other Products
• 2) By Application: Therapeutic; Aesthetic
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Subsegments:
• 1) By Botox: Cosmetic Uses; Therapeutic Uses
• 2) By Dysport: Cosmetic Applications; Medical Indications
• 3) By Xeomin: Cosmetic Treatments; Therapeutic Applications
• 4) By Other Products: Jeuveau; Any Emerging Neurotoxins
• Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals; Merz Pharma GmbH & Co KGaA; Hugel Inc.; Evolus Inc.; Medytox Inc.; Croma-Pharma GmbH; Revance Therapeutics Inc.; US WorldMeds; Gufic Biosciences Ltd.; Hironic Co. Ltd.; Allergan; List Biological Laboratories; Lanzhou Institute of Biological Products Co. Ltd.; Sinclair Pharma; Vida Aesthetics; Aquavit Holdings LLC; PharmaResearch Products Co.Ltd; Entod Pharmaceuticals; Object Pharma Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurotoxin Market Characteristics

3. Neurotoxin Market Trends And Strategies

4. Neurotoxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurotoxin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neurotoxin Market Growth Rate Analysis
• 5.4. Global Neurotoxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neurotoxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neurotoxin Total Addressable Market (TAM)

6. Neurotoxin Market Segmentation

• 6.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botox
• Dysport
• Xeomin
• Other Products
• 6.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic
• Aesthetic
• 6.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users
• 6.4. Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Uses
• Therapeutic Uses
• 6.5. Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Applications
• Medical Indications
• 6.6. Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Treatments
• Therapeutic Applications
• 6.7. Global Neurotoxin Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Jeuveau
• Any Emerging Neurotoxins

7. Neurotoxin Market Regional And Country Analysis

• 7.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurotoxin Market

• 8.1. Asia-Pacific Neurotoxin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurotoxin Market

• 9.1. China Neurotoxin Market Overview
• 9.2. China Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurotoxin Market

• 10.1. India Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurotoxin Market

• 11.1. Japan Neurotoxin Market Overview
• 11.2. Japan Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurotoxin Market

• 12.1. Australia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurotoxin Market

• 13.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurotoxin Market

• 14.1. South Korea Neurotoxin Market Overview
• 14.2. South Korea Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurotoxin Market

• 15.1. Western Europe Neurotoxin Market Overview
• 15.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurotoxin Market

• 16.1. UK Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurotoxin Market

• 17.1. Germany Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurotoxin Market

• 18.1. France Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurotoxin Market

• 19.1. Italy Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurotoxin Market

• 20.1. Spain Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurotoxin Market

• 21.1. Eastern Europe Neurotoxin Market Overview
• 21.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurotoxin Market

• 22.1. Russia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurotoxin Market

• 23.1. North America Neurotoxin Market Overview
• 23.2. North America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurotoxin Market

• 24.1. USA Neurotoxin Market Overview
• 24.2. USA Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurotoxin Market

• 25.1. Canada Neurotoxin Market Overview
• 25.2. Canada Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurotoxin Market

• 26.1. South America Neurotoxin Market Overview
• 26.2. South America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurotoxin Market

• 27.1. Brazil Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurotoxin Market

• 28.1. Middle East Neurotoxin Market Overview
• 28.2. Middle East Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurotoxin Market

• 29.1. Africa Neurotoxin Market Overview
• 29.2. Africa Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurotoxin Market Competitive Landscape And Company Profiles

• 30.1. Neurotoxin Market Competitive Landscape
• 30.2. Neurotoxin Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Supernus Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Neurotoxin Market Other Major And Innovative Companies

• 31.1. Merz Pharma GmbH & Co KGaA
• 31.2. Hugel Inc.
• 31.3. Evolus Inc.
• 31.4. Medytox Inc.
• 31.5. Croma-Pharma GmbH
• 31.6. Revance Therapeutics Inc.
• 31.7. US WorldMeds
• 31.8. Gufic Biosciences Ltd.
• 31.9. Hironic Co. Ltd.
• 31.10. Allergan
• 31.11. List Biological Laboratories
• 31.12. Lanzhou Institute of Biological Products Co. Ltd.
• 31.13. Sinclair Pharma
• 31.14. Vida Aesthetics
• 31.15. Aquavit Holdings LLC

32. Global Neurotoxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurotoxin Market

34. Recent Developments In The Neurotoxin Market

35. Neurotoxin Market High Potential Countries, Segments and Strategies

• 35.1 Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neurotoxin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer